OFATUMUMAB

UNII:	M95KG522R0
Formula:
Preferred Substance Name:	OFATUMUMAB

679818-59-8
2F2
ARZERRA
GSK1841157
GSK-1841157
GSKI841157
HUMAX-CD20
HUMAX-CD20 2F2
HUMAX-CD20, 2F2
HUMAX-CD20-2F2
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN))(HUMAN MONOCLONAL HUMAX-CD20 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL HUMAX-CD20 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN))(HUMAN MONOCLONAL HUMAX-CD20 HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL HUMAX-CD20 .KAPPA.-CHAIN, DIMER
OFATUMUMAB [EMA EPAR]
OFATUMUMAB [INN]
OFATUMUMAB [JAN]
OFATUMUMAB [MART.]
OFATUMUMAB [MI]
OFATUMUMAB [PURPLE BOOK CDER]
OFATUMUMAB [USAN]
OFATUMUMAB [VANDF]
OFATUMUMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

OFATUMUMAB

Synonyms and Mappings

Resources